ResMed Inc. (FRA:RME)

Market Cap	33.71B
Revenue (ttm)	4.38B
Net Income (ttm)	1.19B
Shares Out	n/a
EPS (ttm)	8.10
PE Ratio	28.26
Forward PE	24.55
Dividend	1.98 (0.86%)
Ex-Dividend Date	Aug 14, 2025

Volume	7
Average Volume	32
Open	231.00
Previous Close	230.10
Day's Range	229.60 - 231.00
52-Week Range	180.20 - 250.20
Beta	n/a
RSI	42.00
Earnings Date	Oct 23, 2025

About ResMed

ResMed Inc. develops, manufactures, distributes, and markets medical devices and cloud-based software applications to diagnose, treat, and manage respiratory disorders in the United States and internationally. The company operates in two segments, Sleep and Breathing Health, and Residential Care Software. It offers sleep recorders for the diagnosis and titration of sleep apnea in sleep clinics, hospitals, and at home, including ApneaLink Air, a portable diagnostic device that measures oximetry, respiratory effort, pulse, nasal flow, and snoring...

• Industry: Electromedical and Electrotherapeutic Apparatus
• Founded: 1989
• Employees: 10,600
• Stock Exchange: Frankfurt Stock Exchange
• Ticker Symbol: RME

Financial Performance

In 2025, ResMed's revenue was $5.15 billion, an increase of 9.84% compared to the previous year's $4.69 billion. Earnings were $1.40 billion, an increase of 37.20%.

Financial numbers in USD